98%
921
2 minutes
20
Background: To investigate the relationship between dynamic changes in the neutrophil-to-lymphocyte ratio (NLR) and neurological recovery in noninfected patients with acute cerebral infarction after thrombolysis.
Methods: A retrospective analysis was conducted on 277 patients with stroke thrombolysis. Least absolute shrinkage and selection operator (LASSO) regression was used to identify factors influencing recovery, and 1:1 propensity matching was performed between the groups to compare the changes in the National Institutes of Health Stroke Scale (NIHSS) score, muscle strength, and NLR after treatment. The receiver operating characteristic (ROC) curve was used to determine the cutoff value of NLR reduction after treatment, which serves as a diagnostic criterion for neurologic recovery. The posttreatment NLR reduction values were categorized according to whether they were equal to and greater than the cutoff value. Logistic regression was performed after intergroup matching to analyze the relationship between NLR and NIHSS.
Results: The LASSO regression suggests that increased disease duration and atrial fibrillation are risk factors for neurologic recovery, whereas prolonged treatment duration and increased NLR reduction value are protective factors. Compared with the low-efficacy group, the high-efficacy group exhibited significantly lower NIHSS scores, NLR, and upper and lower extremity muscle strength scores after treatment (p < 0.05). The NLR reduction value was positively correlated with the NIHSS score reduction value and the change in the NIHSS score reduction rate (p < 0.001). The ROC curve and logistic regression indicated that patients with an NLR reduction value of ≥ 0.335 had good recovery.
Conclusions: Higher NLR reduction values indicate an improved neurologic prognosis after treatment.
Trial Registration: Clinical Retrospectively Registered Trials: ChiCTR2100045415.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870821 | PMC |
http://dx.doi.org/10.1002/brb3.70373 | DOI Listing |
Front Immunol
September 2025
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.
Background: Vedolizumab (VDZ) is a monoclonal antibody approved for the treatment of Crohn's disease (CD). Despite its efficacy, non-response to VDZ is common in clinical practice with no clear understanding of how it manifests. Here, we performed an exploratory study characterizing the cellular repertoire of responders and non-responders to VDZ during treatment.
View Article and Find Full Text PDFNeuropsychiatr Dis Treat
August 2025
Shandong Mental Health Center (Affiliated Mental Health Center of Shandong University), Shandong Provincial Key Medical and Health Discipline of Gerontology (Shandong Mental Health Center), Jinan, Shandong, People's Republic of China.
Objective: The aim of this study was to explore the relationship between whole blood cell-derived inflammatory markers and clinical symptoms in patients with late-life depression (LLD). It also aimed to explore the predictive value of whole blood cell-derived inflammatory markers on the efficacy of short-term medication.
Methods: Eighty-three patients with LLD were included, and their baseline demographics, routine blood test results and clinical characteristics before and after 2 weeks of treatment were collected.
J Health Popul Nutr
August 2025
The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
Objective: The present study aimed to evaluate the association between advanced lung cancer inflammation index (ALI) and all-cause mortality in a population of patients with Coronary Heart Disease(CHD) using a retrospective cohort study design.
Methods: Data were obtained from the 1999-2018 National Health and Nutrition Examination Survey (NHANES). ALI was calculated as BMI × albumin level ÷ NLR, integrating anthropometric, nutritional, and inflammatory biomarkers.
In Vivo
August 2025
Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan.
Background/aim: Esophageal squamous cell carcinoma (ESCC) significantly affects nutritional status. While neoadjuvant chemotherapy (NAC) is the standard treatment for clinical stage II/III ESCC, its impact on nutritional status and postoperative outcomes remains unclear. This study investigated the relationship between nutritional deterioration during NAC and outcomes following esophagectomy.
View Article and Find Full Text PDFLife (Basel)
July 2025
Department of Pharmacognosy, Faculty of Pharmacy, Bülent Ecevit University, Zonguldak 67100, Türkiye.
Background: Sternal wound infections (SWIs) remain a significant complication following cardiac surgery. Inflammatory and nutritional status are increasingly recognized as key contributors to their development. This study aimed to investigate the predictive utility of immunonutritional biomarkers and to evaluate the protective effect of combining sternal irrigation with an antibiotic-impregnated membrane.
View Article and Find Full Text PDF